1 2799 139 YOGA THERAPY FOR SOCIAL COGNITION IN SCHIZOPHRENIA: AN EXPERIMENTAL MEDICINE-BASED RANDOMIZED CONTROLLED TRIAL. NEGATIVE SYMPTOMS AND COGNITIVE DEFICITS ARE DIFFICULT-TO-TREAT SYMPTOMS OF SCHIZOPHRENIA. IN THIS SINGLE BLIND RANDOMIZED CONTROLLED STUDY, WE COMPARED CHANGE IN SOCIAL COGNITIVE PERFORMANCE IN PERSONS WITH SCHIZOPHRENIA (PWS) (AS PER DSM-5), AFTER 6 WEEKS OF YOGA INTERVENTION WITH A WAITLIST CONTROL GROUP. WE ALSO EXAMINED CHANGES IN PUTATIVE MIRROR NEURON SYSTEM (MNS) ACTIVITY MEASURED BY TRANSCRANIAL MAGNETIC STIMULATION (TMS) IN A SUBSET OF SAMPLE (N = 30). 51 PWS STABILIZED ON ANTIPSYCHOTIC MEDICATION FOR AT LEAST 6 WEEKS, WERE ASSIGNED TO ADD-ON YOGA THERAPY (YT) (N = 26) OR WAITLIST (WL) (N = 25). SUBJECTS IN THE YT GROUP RECEIVED ADD-ON YOGA THERAPY (20 SESSIONS IN 6 WEEKS). BOTH THE GROUPS CONTINUED THEIR STANDARD TREATMENT AND WERE ASSESSED AT BASELINE AND AFTER 6 WEEKS FOR SOCIAL COGNITION, CLINICAL SYMPTOMS AND SOCIAL DISABILITY. RM-ANOVA SHOWED SIGNIFICANT INTERACTION BETWEEN TIME AND GROUP FOR SOCIAL COGNITION COMPOSITE SCORE (SCCS) (F = 42.09 [1,44], P < 0.001); NEGATIVE SYMPTOMS (SANS) (F = 74.91 [1,45], P < 0.001); POSITIVE SYMPTOMS (SAPS) (F = 16.05 [1,45], P < 0.001) AND SOCIAL DISABILITY (GSDS) (F = 29.91 [1,46], P < 0.001). MNS ACTIVITY HAD INCREASED AFTER 6 WEEKS IN BOTH GROUPS BUT NOT OF STATISTICAL SIGNIFICANCE. THIS STUDY DEMONSTRATES THAT 6 WEEKS OF ADD-ON YOGA THERAPY COULD IMPROVE SOCIAL COGNITION IN PWS COMPARED TO WAITLIST CONTROL SUBJECTS. HOWEVER, THE CHANGE IN SOCIAL COGNITION WAS NOT ASSOCIATED WITH A CHANGE IN THE PUTATIVE MNS-ACTIVITY. IT NECESSIATATES FURTHER STUDIES TO INVESTIGATE THE MECHANISTIC PROCESSES OF YOGA AND REPLICATE THESE OBSERVATIONS IN A LARGER SAMPLE. 2021 2 270 45 ADD ON YOGA TREATMENT FOR NEGATIVE SYMPTOMS OF SCHIZOPHRENIA: A MULTI-CENTRIC, RANDOMIZED CONTROLLED TRIAL. THE EFFICACY OF ANTIPSYCHOTIC MEDICATIONS IN THE TREATMENT OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA IS MODEST AT BEST. PRELIMINARY STUDIES SUGGEST THE BENEFICIAL EFFECTS OF ADD ON YOGA, A TRADITIONAL INDIAN PRACTICE, IN THE TREATMENT OF SCHIZOPHRENIA. HENCE, IN THIS STUDY, WE EXAMINED THE EFFICACY OF YOGA AS AN ADD-ON TREATMENT FOR NEGATIVE SYMPTOMS OF SCHIZOPHRENIA IN A RANDOMIZED, WAIT-LIST CONTROLLED DESIGN FROM TWO CLINICAL INSTITUTES IN SOUTH INDIA. 89 PATIENTS (AGE - 34.20 +/- 8.06 YEARS; EDUCATION - 14.22 +/- 2.69 YEARS; 28 FEMALES) WERE RANDOMIZED INTO THE ADD-ON YOGA OR TREATMENT AS USUAL (TAU - WAIT-LIST CONTROL) GROUP. PATIENTS HAD A MEAN ILLNESS DURATION OF 10.97 +/- 7.24 YEARS WITH AN AGE AT ONSET OF 23.34 +/- 5.81 YEARS. CENTRAL BLOCK RANDOMIZATION WAS FOLLOWED TO ENSURE CONCEALED ALLOCATION. PARTICIPANTS RANDOMIZED TO THE YOGA TREATMENT GROUP ATTENDED 12 SUPERVISED YOGA TRAINING SESSIONS OVER TWO WEEKS AND PRACTICED YOGA SESSIONS AT HOME FOR THE SUBSEQUENT 10 WEEKS. 64 PATIENTS COMPLETED THE TRIAL. AN INTENT TO TREAT ANALYSIS WAS CONDUCTED WITH 89 PARTICIPANTS USING A LINEAR MIXED MODEL. IMPROVEMENT IN NEGATIVE SYMPTOMS WAS OUR PRIMARY OUTCOME MEASURE. THE TWO GROUPS WERE MATCHED ON DEMOGRAPHIC VARIABLES AND BASELINE PSYCHOPATHOLOGY SEVERITY. PARTICIPANTS IN THE ADD-ON YOGA GROUP HAD SIGNIFICANTLY GREATER IMPROVEMENT IN NEGATIVE SYMPTOMS (SANS BASELINE: 49.13 +/- 2.30; 12-WEEKS FOLLOW UP: 31.55 +/- 2.53) COMPARED TO THE TAU GROUP (SANS BASELINE: 51.22 +/- 2.40; 12-WEEKS FOLLOW UP: 45.30 +/- 2.93; T = 3.36; P = 0.006; COHEN'S D-0.65). THE CURRENT STUDY FINDINGS SUGGEST THE EFFICACY OF YOGA AS AN ADD-ON TREATMENT FOR NEGATIVE SYMPTOMS OF SCHIZOPHRENIA. THE EFFECTIVENESS OF YOGA PRACTICE AS A REGULAR CLINICAL INTERVENTION FOR PATIENTS NEEDS TO BE EXPLORED IN FUTURE STUDIES BY INTEGRATING YOGA SERVICES ALONG WITH OTHER CLINICAL SERVICES. 2021 3 2785 45 YOGA THERAPY AS AN ADJUNCTIVE TREATMENT FOR SCHIZOPHRENIA: A RANDOMIZED, CONTROLLED PILOT STUDY. OBJECTIVES: THERE HAS BEEN LIMITED STUDY OF THERAPEUTIC YOGA AS A COMPLEMENTARY TREATMENT FOR SCHIZOPHRENIA. THIS STUDY INVESTIGATES THE EFFECTS OF A YOGA THERAPY PROGRAM ON SYMPTOMATOLOGY AND QUALITY OF LIFE IN ADULTS WITH SCHIZOPHRENIA IN A STATE PSYCHIATRIC FACILITY. METHODS: IN A RANDOMIZED, CONTROLLED PILOT STUDY, 18 CLINICALLY STABLE PATIENTS (12 MEN AND 6 WOMEN) WITH SCHIZOPHRENIA (MEAN AGE=42+/-13.5) WERE RANDOMIZED TO AN 8-WEEK YOGA THERAPY PROGRAM (YT) AND A WAITLIST GROUP (WL). YT INTERVENTION INCLUDED YOGA POSTURES, BREATHING EXERCISES, AND RELAXATION. AT BASELINE AND AT 8 WEEKS, SYMPTOMATOLOGY WAS MEASURED USING THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS). SECONDARY EFFICACY OUTCOMES WERE MEASURED WITH THE WORLD HEALTH ORGANIZATION QUALITY OF LIFE BREF QUESTIONNAIRE (WHOQOL-BREF). RESULTS: THE YT GROUP OBTAINED SIGNIFICANT IMPROVEMENTS IN POSITIVE AND NEGATIVE SYMPTOMS OF SCHIZOPHRENIA SYMPTOMS COMPARED TO WL, INCLUDING PANSS SCORES ON POSITIVE SYNDROME (T=-2.64, P=0.02), NEGATIVE SYNDROME (T=-3.04, P<0.01), GENERAL PSYCHOPATHOLOGY (T=-3.74, P<0.00), ACTIVATION (T=-2.29, P<0.04), PARANOIA (T=-2.89, P<0.01), AND DEPRESSION SUBSCALES (T=-2.62, P<0.02). PANSS TOTAL SCORES ALSO DECREASED FOR THE YT GROUP (T=-4.54, P<0.00). YT HAD IMPROVED PERCEIVED QUALITY OF LIFE IN PHYSICAL (T=2.38, P<0.04) AND PSYCHOLOGIC DOMAINS (T=2.88, P<0.01). CONCLUSIONS: ADULTS WITH SCHIZOPHRENIA BEING TREATED IN A STATE PSYCHIATRIC FACILITY WHO PARTICIPATED IN AN 8-WEEK THERAPEUTIC YOGA PROGRAM SHOWED SIGNIFICANT IMPROVEMENTS IN PSYCHOPATHOLOGY AND QUALITY OF LIFE COMPARED WITH CONTROLS. THE FINDINGS OF THIS STUDY NEED TO BE CONFIRMED IN LARGER, MORE SUFFICIENTLY POWERED STUDIES WITH ACTIVE CONTROL GROUPS. 2011 4 1833 32 PSYCHOLOGICAL WELLNESS, YOGA AND QUALITY OF LIFE IN PATIENTS AFFECTED BY SCHIZOPHRENIA SPECTRUM DISORDERS: A PILOT STUDY. SCHIZOPHRENIA IS A SERIOUS PSYCHIATRIC DISORDER CHARACTERIZED BY POSITIVE SYMPTOMS, NEGATIVE SYMPTOMS AND NEUROCOGNITIVE DEFICITS. THE AIM OF THIS STUDY WAS TO ESTIMATE RELATIONSHIPS BETWEEN WELLNESS, YOGA AND QUALITY OF LIFE IN PATIENTS AFFECTED BY SCHIZOPHRENIA SPECTRUM DISORDERS. PARTICIPANTS WERE 30 PATIENTS WITH A DIAGNOSIS OF SCHIZOPHRENIA IN CARE AT THE REHABILITATIVE PSYCHIATRY AND RESEARCH VILLA CHIARA CLINIC IN MASCALUCIA (CATANIA, ITALY), AFTER THAT RANDOMLY ASSIGNED TO TWO GROUPS. THE FIRST GROUP FOLLOWED THE EXPERIMENTAL TREATMENT WITH SETS OF YOGA EXERCISES CONDUCTED BY A YOGA TRAINER AND A PSYCHIATRIST OR A CLINICAL PSYCHOLOGIST EXPERT IN YOGA, WHILE A SECOND CONTROL GROUP WAS TREATED WITH USUAL CARE. THE RESULTS REVEALED A SIGNIFICANT DIFFERENCE, BEFORE AND AFTER TREATMENT, BETWEEN THE EXPERIMENTAL GROUP AND THE CONTROL GROUP IN QUALITY OF LIFE. 2019 5 2653 50 YOGA IMPROVES OCCUPATIONAL PERFORMANCE, DEPRESSION, AND DAILY ACTIVITIES FOR PEOPLE WITH CHRONIC PAIN. BACKGROUND: CHRONIC PAIN IS A COMPLEX ACCUMULATION OF PHYSICAL, PSYCHOLOGICAL, AND SOCIAL CONDITIONS, THUS INTERVENTIONS THAT ADDRESS PAIN AND PROMOTE OCCUPATIONAL PERFORMANCE ARE NEEDED. A HOLISTIC INTERVENTION, WITH MIND AND BODY COMPONENTS, IS LIKELY NECESSARY TO BEST TREAT THE COMPLEXITIES OF CHRONIC PAIN. THUS, WE DEVELOPED AND TESTED A YOGA INTERVENTION FOR PEOPLE WITH CHRONIC PAIN. OBJECTIVES: IN A RANDOMIZED CONTROL TRIAL (RCT), PARTICIPANTS WITH CHRONIC PAIN WERE RANDOMIZED TO A YOGA INTERVENTION OR USUAL CARE GROUP. BETWEEN AND WITHIN GROUP DIFFERENCES FOR PRE-AND POST-OUTCOME MEASURE SCORES WERE ASSESSED FOR: OCCUPATIONAL PERFORMANCE, COMPLETION OF ACTIVITIES, AND DEPRESSION. METHODS: PILOT RCT WITH PARTICIPANT ALLOCATION TO 8 WEEKS OF YOGA OR USUAL CARE. BOTH GROUPS RECEIVED ONGOING MONTHLY SELF-MANAGEMENT PROGRAMMING. DATA WERE COLLECTED BEFORE AND AFTER THE 8-WEEK INTERVENTION. PARTICIPANTS WERE RANDOMIZED TO YOGA OR USUAL CARE AFTER BASELINE ASSESSMENTS. DEMOGRAPHICS WERE COLLECTED AND MEASURES INCLUDED: CANADIAN OCCUPATIONAL PERFORMANCE MEASURE (COPM) TO ASSESS OCCUPATIONAL PERFORMANCE; THE 15-ITEM FRENCHAY ACTIVITIES INDEX (FAI)(ACTIVITIES); AND THE 9-ITEM PATIENT HEALTH QUESTIONNAIRE (PHQ-9) FOR DEPRESSION. INDEPENDENT T-TESTS WERE USED TO ASSESS DIFFERENCES BETWEEN GROUPS. PAIRED T-TESTS WERE USED TO ASSESS DIFFERENCES BETWEEN PRE- AND POST 8-WEEK INTERVENTION FOR BOTH THE YOGA AND THE USUAL CARE GROUPS. PERCENT CHANGE SCORES AND EFFECT SIZES WERE CALCULATED. RESULTS: 83 PEOPLE WERE RECRUITED FOR THE STUDY AND COMPLETED BASELINE ASSESSMENTS; 44 INDIVIDUALS WERE RANDOMIZED TO YOGA AND 39 TO THE CONTROL GROUP. THE AVERAGE AGE OF ALL PARTICIPANTS WAS 51.4+/-10.5 YEARS, 68% WERE FEMALE; AND 60% HAD AT LEAST SOME COLLEGE EDUCATION. THERE WERE NO SIGNIFICANT DIFFERENCES IN DEMOGRAPHICS OR OUTCOME MEASURES BETWEEN GROUPS AT BASELINE OR 8 WEEKS; HOWEVER, THE STUDY WAS NOT POWERED TO SEE SUCH DIFFERENCES. INDIVIDUALS RANDOMIZED TO THE CONTROL GROUP DID NOT SIGNIFICANTLY IMPROVE IN ANY OUTCOME MEASURE OVER THE 8 WEEKS. THERE WERE SIGNIFICANT IMPROVEMENTS IN COPM PERFORMANCE AND COPM SATISFACTION SCORES FOR INDIVIDUALS RANDOMIZED TO THE YOGA GROUP; BOTH SCORES SIGNIFICANTLY IMPROVED. COPM PERFORMANCE IMPROVED BY 27% WITH A MODERATE TO LARGE EFFECT SIZE (3.66+/-1.85 VS 4.66+/-1.93, P < 0.001, D = 0.76). COPM SATISFACTION SIGNIFICANTLY IMPROVED BY 78% (2.14+/-2.31 VS. 3.80+/-2.50, P < 0.001) AND HAD A LARGE EFFECTS SIZE (D = 1.02). FAI SCORES IMPROVED, INDICATING INCREASED ACTIVITY OR ENGAGEMENT IN DAILY OCCUPATION DURING THE 8-WEEK INTERVENTION. SCORES INCREASED BY 5% (38.13+/-8.48 VS. 39.90+/-8.57, P = 0.024) WITH A SMALL EFFECT SIZE (D = 0.37). DEPRESSION SIGNIFICANTLY DECREASED FROM 13.21+/-5.60 TO 11.41+/-5.82, P = 0.041, WITH A SMALL EFFECT SIZE. CONCLUSION: DATA FROM THIS PILOT RCT INDICATE YOGA MAY BE AN EFFECTIVE THERAPEUTIC INTERVENTION WITH PEOPLE IN CHRONIC PAIN TO IMPROVE OCCUPATIONAL PERFORMANCE, INCREASE ENGAGEMENT IN ACTIVITIES, AND DECREASE DEPRESSION. OCCUPATIONAL THERAPY PRACTITIONERS MAY CONSIDER ADDING YOGA AS A TREATMENT INTERVENTION TO ADDRESS THE NEEDS OF PEOPLE WITH PAIN. 2019 6 277 39 ADDITIONAL PRACTICE OF YOGA BREATHING WITH INTERMITTENT BREATH HOLDING ENHANCES PSYCHOLOGICAL FUNCTIONS IN YOGA PRACTITIONERS: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND AND OBJECTIVE: THE PRACTICE OF YOGA IS ASSOCIATED WITH ENHANCED PSYCHOLOGICAL WELLBEING. THE CURRENT STUDY ASSESSED THE CORRELATION BETWEEN THE DURATION OF YOGA PRACTICE WITH STATE MINDFULNESS, MIND-WANDERING AND STATE ANXIETY. ALSO, WE EXAMINED IF AN ADDITIONAL 20 MIN OF YOGA BREATHING WITH INTERMITTENT BREATH HOLDING (EXPERIMENTAL GROUP) FOR 8 WEEKS WOULD AFFECT THESE PSYCHOLOGICAL VARIABLES MORE THAN REGULAR YOGA PRACTICE (CONTROL GROUP) ALONE. METHODS: ONE HUNDRED SIXTEEN SUBJECTS WERE RANDOMLY ASSIGNED TO EXPERIMENTAL (N = 60) AND CONTROL (N = 56) GROUPS. STATE MINDFULNESS ATTENTION AWARENESS SCALE (SMAAS), MIND-WANDERING QUESTIONNAIRE (MWQ) AND STATE ANXIETY INVENTORY WERE ADMINISTERED AT BASELINE AND AT THE END OF 8 WEEKS. RESULTS: BASELINE ASSESSMENT REVEALED A POSITIVE CORRELATION BETWEEN DURATION OF YOGA PRACTICE WITH SMAAS SCORES AND NEGATIVE CORRELATION WITH MWQ AND STATE ANXIETY SCORES. AT THE END OF 8 WEEKS, BOTH GROUPS DEMONSTRATED ENHANCED PSYCHOLOGICAL FUNCTIONS, BUT THE EXPERIMENTAL GROUP RECEIVING ADDITIONAL YOGA BREATHING PERFORMED BETTER THAN THE GROUP PRACTICING YOGA ALONE. CONCLUSION: AN ADDITIONAL PRACTICE OF YOGA BREATHING WITH INTERMITTENT BREATH HOLDING WAS FOUND TO ENHANCE THE PSYCHOLOGICAL FUNCTIONS IN YOUNG ADULT YOGA PRACTITIONERS. 2018 7 97 28 A NONRANDOMIZED COMPARISON STUDY OF SELF-HYPNOSIS, YOGA, AND COGNITIVE-BEHAVIORAL THERAPY TO REDUCE EMOTIONAL DISTRESS IN BREAST CANCER PATIENTS. THE AUTHORS ASKED BREAST CANCER (BC) PATIENTS TO PARTICIPATE IN 1 OF 3 MIND-BODY INTERVENTIONS (COGNITIVE-BEHAVIORAL THERAPY (CBT), YOGA, OR SELF-HYPNOSIS) TO EXPLORE THEIR FEASIBILITY, EASE OF COMPLIANCE, AND IMPACT ON THE PARTICIPANTS' DISTRESS, QUALITY OF LIFE (QOL), SLEEP, AND MENTAL ADJUSTMENT. NINETY-NINE PATIENTS COMPLETED AN INTERVENTION (CBT: N = 10; YOGA: N = 21; AND SELF-HYPNOSIS: N = 68). RESULTS SHOWED HIGH FEASIBILITY AND HIGH COMPLIANCE. AFTER THE INTERVENTIONS, THERE WAS NO SIGNIFICANT EFFECT IN THE CBT GROUP BUT SIGNIFICANT POSITIVE EFFECTS ON DISTRESS IN THE YOGA AND SELF-HYPNOSIS GROUPS, AND, ALSO, ON QOL, SLEEP, AND MENTAL ADJUSTMENT IN THE SELF-HYPNOSIS GROUP. IN CONCLUSION, MIND-BODY INTERVENTIONS CAN DECREASE DISTRESS IN BC PATIENTS, BUT RCTS ARE NEEDED TO CONFIRM THESE FINDINGS. 2017 8 2103 31 THE EFFECT OF YOGA ON FUNCTIONAL RECOVERY LEVEL IN SCHIZOPHRENIC PATIENTS. PURPOSE: THE OBJECTIVE OF THIS STUDY IS TO DETERMINE THE EFFECT OF YOGA ON FUNCTIONAL RECOVERY LEVEL IN SCHIZOPHRENIC PATIENTS. MATERIALS AND METHODS: THE STUDY WAS CONDUCTED IN QUASI-EXPERIMENTAL DESIGN WITH PRETEST-POSTTEST CONTROL GROUP. THE POPULATION OF THE STUDY CONSISTED OF SCHIZOPHRENIC PATIENTS WITH REGISTERED IN MALATYA AND ELAZIG COMMUNITY MENTAL HEALTH CENTERS AND REGULARLY GOING TO THESE CENTERS. THE SAMPLE GROUP OF THE STUDY CONSISTED OF TOTALLY 100 PATIENTS INCLUDING 50 PATIENTS IN THE EXPERIMENTAL GROUP AND 50 PATIENTS IN THE CONTROL GROUP WHO WERE SPECIFIED THROUGH POWER ANALYSIS AND CHOSEN BY USING RANDOM SAMPLING METHOD FROM THIS POPULATION. THE DATA WERE COLLECTED BETWEEN APRIL 2015 AND AUGUST 2015. 'PATIENT DESCRIPTION FORM' AND 'FROGS' WERE USED TO COLLECT THE DATA. YOGA WAS APPLIED TO PATIENTS IN THE EXPERIMENTAL GROUP. ANY INTERVENTION WAS NOT MADE TO PATIENTS IN THE CONTROL GROUP. PERCENTAGE DISTRIBUTION, ARITHMETIC MEAN, STANDARD DEVIATION, CHI-SQUARE, INDEPENDENT SAMPLES T TEST, AND PAIRED T TEST WERE USED TO ASSESS THE DATA. RESULTS: PATIENTS IN THE CONTROL AND EXPERIMENTAL GROUP PRETEST SUBSCALE AND THE TOTAL MEANS SCORES OF FROGS WAS FOUND TO BE LOW. IN THE POSTTEST SUBSCALE AND TOTAL MEANS SCORES OF FROGS IN THE EXPERIMENTAL GROUP WERE HIGHER THAN IN THE CONTROL GROUP AND THE DIFFERENCES BETWEEN THEM WERE FOUND TO BE STATISTICALLY SIGNIFICANT (P<0.05). IN THE EXPERIMENTAL GROUP PRETEST AND POSTTEST SUBSCALE AND TOTAL MEANS SCORES OF FR0GS WAS DETERMINED TO BE STATISTICALLY SIGNIFICANT (P<0.05). CONCLUSION: YOGA THAT APPLIED TO SCHIZOPHRENIC PATIENTS IT WAS DETERMINED TO INCREASED THE LEVEL OF FUNCTIONAL RECOVERY. IT CAN BE SUGGESTED THAT YOGA SHOULD BE USED AS AN COMPLEMENTARY METHOD IN NURSING PRACTISE IN ORDER TO INCREASE THE EFFECTIVENESS OF THE TREATMENT. 2016 9 2073 39 THE EFFECT OF A STRETCH AND STRENGTH-BASED YOGA EXERCISE PROGRAM ON PATIENTS WITH NEUROPATHIC PAIN DUE TO LUMBAR DISC HERNIATION. STUDY DESIGN: RANDOMIZED CONTROLLED TRIAL. OBJECTIVE: TO INVESTIGATE THE EFFECT OF A STRETCH AND STRENGTHBASED YOGA EXERCISE PROGRAM ON NEUROPATHIC PAIN DUE TO LDH. SUMMARY OF BACKGROUND DATA: LDH WITH NEUROPATHIC PAIN INFLUENCES TREATMENT OUTCOMES NEGATIVELY. MOST YOGA POSES INCLUDE THE PARAMETERS OF SPINAL TRAINING AND HELP REDUCE PAIN AND DISABILITY IN PATIENTS WITH LOW BACK INJURIES. WE HYPOTHESIZED THAT YOGA POSITIVELY AFFECTS BOTH LDH AND NEUROPATHIC PAIN BY INCREASING MOBILIZATION, CORE MUSCLE STRENGTH, AND SPINAL AND HAMSTRING FLEXIBILITY. METHODS: IN TOTAL, 48 PATIENTS WITH NEUROPATHIC PAIN DUE TO LDH WERE RANDOMLY ASSIGNED TO A CONTROL GROUP AND A YOGA GROUP. ALL PATIENTS UNDERWENT A PATIENT EDUCATION PROGRAM. IN ADDITION, THE SELECTED YOGA EXERCISE WAS TAUGHT AND PERFORMED TO THE YOGA GROUP FOR ONE HOUR TWICE WEEKLY FOR 12 WEEKS. NEUROPATHIC PAIN (DOULEUR NEUROPATHIQUE 4 FOR DIAGNOSIS; LEEDS ASSESSMENT OF NEUROPATHIC SYMPTOMS AND SIGNS FOR SEVERITY), LOW BACK PAIN (THE SHORT-FORM OF MCGILL PAIN QUESTIONNAIRE), DISABILITY (OSWESTRY DISABILITY INDEX), AND FUNCTION (MODIFIED SCHOBER AND PASSIVE KNEE EXTENSION TEST) WERE MEASURED BLIND BEFORE AND AT THE ONE-, THREE-, AND SIX-MONTH FOLLOW-UPS. THE PATIENT GLOBAL ASSESSMENT WAS APPLIED AT THE SIX-MONTH FOLLOWUP. THE INTENTION-TO-TREAT ANALYSIS WAS PERFORMED IN THIS STUDY. RESULTS: THE INTENTION-TO-TREAT ANALYSIS SHOWED A STATISTICALLY SIGNIFICANT DIFFERENCE IN NEUROPATHIC PAIN, PATIENT GLOBAL ASSESS MENT, LOW BACK PAIN, DISABILITY, AND FUNCTION IN FAVOR OF THE YOGA GROUP AT POST-TREATMENT. THE BETWEEN-GROUP EFFECT SIZES WERE MODERATE AT SIX-MONTHS FOLLOW-UP. CONCLUSION: IT WAS DETERMINED THAT THE SELECTED STRETCH AND STRENGTH-BASED YOGA EXERCISE COULD BE A PROMISING TREATMENT OPTION FOR NEUROPATHIC PAIN DUE TO LDH. LEVEL OF EVIDENCE: 2. 2022 10 2112 29 THE EFFECT OF YOGA ON STRESS, ANXIETY, AND DEPRESSION IN WOMEN. BACKGROUND: IN RECENT DECADES, SEVERAL MEDICAL AND SCIENTIFIC STUDIES ON YOGA PROVED IT TO BE VERY USEFUL IN THE TREATMENT OF SOME DISEASES. THIS STUDY WAS CONDUCTED TO INVESTIGATE THE EFFECTS OF YOGA ON STRESS, ANXIETY, AND DEPRESSION IN WOMEN LIVING IN ILAM, IRAN. METHODS: THIS STUDY IS A QUASI-EXPERIMENTAL STUDY WITH PRE-POST TEST. TO COLLECT DATA, THE QUESTIONNAIRE OF DASS-21 (DEPRESSION ANXIETY STRESS SCALE-21) WAS USED. FOR ELIGIBLE SAMPLES, HATHA YOGA EXERCISES AND TRAINING SESSIONS WERE HELD FOR 4 WEEKS (3 TIME/WEEKS; 60-70 MIN EACH) BY A SPECIALIST. DATA WERE ANALYZED USING SPSS VERSION 20. RESULTS: 52 WOMEN WITH A MEAN AGE OF 33.5 +/- 6.5 WERE INCLUDED FOR ANALYSIS. DEPRESSION, ANXIETY, AND STRESS DECREASED SIGNIFICANTLY IN WOMEN AFTER 12 SESSIONS OF REGULAR HATHA YOGA PRACTICE (P < 0.001). CONCLUSIONS: YOGA HAS AN EFFECTIVE ROLE IN REDUCING STRESS, ANXIETY, AND DEPRESSION. THUS, IT CAN BE USED AS COMPLEMENTARY MEDICINE. 2018 11 2173 27 THE EFFECTS OF YOGA ON DYSPNEA, SLEEP AND FATIGUE IN CHRONIC RESPIRATORY DISEASES. PURPOSE: THIS STUDY WAS CARRIED OUT TO FIND OUT THE EFFECTS OF YOGA APPLIED TO CHRONIC RESPIRATORY DISEASE PATIENTS ON DYSPNEA, SLEEP QUALITY AND FATIGUE. MATERIAL AND METHOD: THE STUDY WAS CONDUCTED BETWEEN MAY AND AUGUST 2020 AS A RANDOMIZED CONTROLLED STUDY. 'PERSONAL INFORMATION FORM', 'RESPIRATORY FUNCTIONS MONITORING FORM', 'COPD AND ASTHMA FATIGUE SCALE (CAFS), "ASTHMA AND COPD SLEEP IMPACT SCALE (CASIS)" AND MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCALE (MMRC) WERE USED IN DATA COLLECTION. RESULTS: WHEN THE POST-TEST MEAN SCORES OF THE PATIENTS IN THE EXPERIMENTAL AND CONTROL GROUP WERE COMPARED, IT WAS FOUND THAT CAFS, CASIS AND MMRC MEAN SCORES OF THE PATIENTS IN THE EXPERIMENTAL GROUP DECREASED POSITIVELY COMPARED TO THE PATIENTS IN THE CONTROL GROUP AND THE DIFFERENCE BETWEEN WAS FOUND TO BE STATISTICALLY SIGNIFICANT (P < 0.05). CONCLUSION: YOGA HAS BEEN FOUND TO REDUCE THE SEVERITY OF DYSPNEA AND FATIGUE AND IMPROVE SLEEP QUALITY IN CHRONIC RESPIRATORY DISEASES. 2021 12 2319 35 TREATING THE CLIMACTERIC SYMPTOMS IN INDIAN WOMEN WITH AN INTEGRATED APPROACH TO YOGA THERAPY: A RANDOMIZED CONTROL STUDY. OBJECTIVE: TO STUDY THE EFFECT OF YOGA ON THE CLIMACTERIC SYMPTOMS, PERCEIVED STRESS, AND PERSONALITY IN PERIMENOPAUSAL WOMEN. DESIGN: ONE HUNDRED TWENTY PARTICIPANTS (AGES 40-55 Y) WERE RANDOMLY DIVIDED INTO TWO STUDY ARMS, IE, YOGA AND CONTROL. THE YOGA GROUP PRACTICED AN INTEGRATED APPROACH TO YOGA THERAPY COMPRISING SURYA NAMASKARA (SUN SALUTATION) WITH 12 POSTURES, PRANAYAMA (BREATHING PRACTICES), AND AVARTAN DHYAN (CYCLIC MEDITATION), WHEREAS THE CONTROL GROUP PRACTICED A SET OF SIMPLE PHYSICAL EXERCISES UNDER SUPERVISION OF TRAINED TEACHERS FOR 8 WEEKS (1 H DAILY, 5 DAYS PER WEEK). THE ASSESSMENTS WERE MADE BY GREENE CLIMACTERIC SCALE, PERCEIVED STRESS SCALE, AND EYSENCK'S PERSONALITY INVENTORY BEFORE AND AFTER THE INTERVENTION. RESULTS: OF THE THREE FACTORS OF THE GREENE CLIMACTERIC SCALE, THE MANN-WHITNEY TEST SHOWED A SIGNIFICANT DIFFERENCE BETWEEN GROUPS (P < 0.05) IN THE VASOMOTOR SYMPTOMS, A MARGINALLY SIGNIFICANT DIFFERENCE (P = 0.06) IN PSYCHOLOGICAL FACTORS BUT NOT IN THE SOMATIC COMPONENT. EFFECT SIZES WERE HIGHER IN THE YOGA GROUP FOR ALL FACTORS. THERE WAS A SIGNIFICANTLY GREATER DEGREE OF DECREASE IN PERCEIVED STRESS SCALE SCORES (P < 0.001, INDEPENDENT SAMPLES T TEST) IN THE YOGA GROUP COMPARED WITH CONTROLS (BETWEEN-GROUP ANALYSIS) WITH A HIGHER EFFECT SIZE IN THE YOGA GROUP (1.10) THAN THE CONTROL (0.27). ON THE EYSENCK'S PERSONALITY INVENTORY, THE DECREASE IN NEUROTICISM WAS GREATER (P < 0.05) IN THE YOGA GROUP (EFFECT SIZE = 0.43) THAN THE CONTROL GROUP (EFFECT SIZE = 0.21) WITH NO CHANGE IN EXTROVERSION IN EITHER THE YOGA OR CONTROL GROUP. CONCLUSIONS: EIGHT WEEKS OF AN INTEGRATED APPROACH TO YOGA THERAPY DECREASES CLIMACTERIC SYMPTOMS, PERCEIVED STRESS, AND NEUROTICISM IN PERIMENOPAUSAL WOMEN BETTER THAN PHYSICAL EXERCISE. 2008 13 1046 33 EFFECTS OF YOGA ON ANXIETY AND DEPRESSION FOR HIGH RISK MOTHERS ON HOSPITAL BEDREST. BACKGROUND: AND PURPOSE: IN RECENT YEARS, YOGA PRACTITIONERS HAVE JOINED FORCES WITH MEDICAL PROGRAMS TO APPROACH PATIENTS' WELL-BEING HOLISTICALLY. THIS STUDY IS A RANDOMIZED CONTROLLED TRIAL TO ASSESS THE EFFECTS OF A SPECIALIZED ADAPTED YOGA PROGRAM ON ANXIETY AND DEPRESSION FOR HIGH-RISK EXPECTANT MOTHERS ON BEDREST IN A HOSPITAL SETTING. MATERIALS AND METHODS: SEVENTY-NINE PREGNANT SUBJECTS ON PHYSICIAN ORDERED HOSPITALIZED BEDREST WERE RANDOMIZED INTO TWO GROUPS: RECEIVING BIWEEKLY YOGA SESSIONS (INTERVENTION GROUP) OR RECEIVING NO YOGA (CONTROL GROUP). DATA COLLECTION TOOL WAS THE HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) TO ASSESS OUTCOMES AFTER DELIVERY. RESULTS: YOGA, EVEN AS LITTLE AS THREE SESSIONS, SHOWED SIGNIFICANT IMPACT IN REDUCING ANXIETY AND DEPRESSION HIGH-RISK PREGNANT WOMEN ON HOSPITALIZED BEDREST. PERCEIVED ANXIETY AND DEPRESSION OVERALL SCORES WERE LOWER IN THE INTERVENTION GROUP THAN IN THE CONTROL GROUP (P < 0.001). CONCLUSION: RESULTS DEMONSTRATED THAT YOGA IS AN EFFECTIVE INTERVENTION TO DECREASE ANXIETY AND DEPRESSION IN HIGH-RISK ANTEPARTUM WOMEN ON HOSPITALIZED BEDREST. 2020 14 2461 31 YOGA AS A NOVEL ADJUVANT THERAPY FOR PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES. CONTEXT: RECENT STUDIES HAVE DEMONSTRATED THAT PHYSICAL ACTIVITY IS WELL TOLERATED BY PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) AND CAN HAVE ADDITIONAL BENEFITS AS AN ADJUVANT THERAPY TO PHARMACOLOGIC AGENTS, ESPECIALLY IF STARTED EARLY. TO DATE, NO STUDIES HAVE EXAMINED THE EFFECTS OF YOGA ON PATIENTS WITH IIMS. AIMS: THE AIM OF THIS STUDY WAS TO EVALUATE THE EFFECTS OF YOGA ON SELF-REPORTED DIFFICULTY IN PERFORMING ACTIVITIES OF DAILY LIVING (ADL) AND MUSCLE STRENGTH IN PATIENTS WITH MILD-TO-MODERATE IIMS. SUBJECTS AND METHODS: A LONGITUDINAL COHORT STUDY IN WHICH PARTICIPANTS WERE ASSESSED USING THE MYOSITIS ACTIVITIES PROFILE (MAP) AND MANUAL MUSCLE TESTING (MMT) BEFORE AND AFTER THE COMPLETION OF AN 8-WEEK INSTRUCTOR-GUIDED YOGA COURSE WAS PERFORMED. STATISTICAL ANALYSIS USED: WILCOXON SIGNED-RANKED TEST WAS PERFORMED FOR STATISTICAL ANALYSIS. RESULTS: THE AVERAGE POSTTREATMENT MAP SCORES OF SIX PARTICIPANTS DEMONSTRATED AN INCREASE OF 2.51 POINTS, WHILE THE AVERAGE MMT SCORE OF FOUR PARTICIPANTS DEMONSTRATED AN INCREASE OF 11 POINTS. CONCLUSIONS: THIS STUDY IS THE FIRST STUDY TO DATE TO EXAMINE THE EFFECT OF YOGA AS AN ADJUVANT COMPLEMENTARY THERAPY FOR PATIENTS WITH IIM. CONTINUED RESEARCH SHOULD BE DONE ON THE EFFECT OF YOGA AS AN ADJUVANT THERAPY, FOR IN ADDITION TO INCREASE IN MUSCLE STRENGTH AND ABILITY TO PERFORM ADL, YOGA MAY OFFER POTENTIAL IMPROVEMENTS IN MOOD, MENTAL HEALTH, AND SLEEP. 2021 15 2789 37 YOGA THERAPY FOR ABDOMINAL PAIN-RELATED FUNCTIONAL GASTROINTESTINAL DISORDERS IN CHILDREN: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: THE AIM OF THE PRESENT STUDY WAS TO COMPARE EFFECTS OF 10 WEEKS OF YOGA THERAPY (YT) AND STANDARD MEDICAL CARE (SMC) ON ABDOMINAL PAIN AND QUALITY OF LIFE (QOL) IN CHILDREN WITH ABDOMINAL PAIN-RELATED FUNCTIONAL GASTROINTESTINAL DISORDERS (AP-FGIDS). METHODS: SIXTY-NINE PATIENTS, AGES 8 TO 18 YEARS, WITH AP-FGIDS, WERE RANDOMIZED TO SMC COMPLEMENTED WITH YT OR SMC ALONE. YT IS A MIXTURE OF YOGA POSES, MEDITATION, AND RELAXATION EXERCISES AND WAS GIVEN ONCE A WEEK IN GROUP SESSIONS. SMC CONSISTED OF EDUCATION, REASSURANCE, DIETARY ADVICE, AND FIBERS/MEBEVERINE, IF NECESSARY. PAIN INTENSITY (PAIN INTENSITY SCORE [PIS] 0-5) AND FREQUENCY (PAIN FREQUENCY SCORE [PFS] 0-4) WERE SCORED IN A PAIN DIARY, AND QOL WAS MEASURED WITH KIDSCREEN-27. FOLLOW-UP WAS 12 MONTHS. TREATMENT RESPONSE WAS DEFINED AS >/=50% REDUCTION OF WEEKLY PAIN SCORES. RESULTS: AT 1-YEAR FOLLOW-UP, TREATMENT RESPONSE WAS ACCOMPLISHED IN 58% OF THE YT GROUP AND IN 29% OF THE CONTROL GROUP (P = 0.01); NO SIGNIFICANT DIFFERENCES FOR OTHER TIME POINTS WERE FOUND. YT, AND NOT SMC, RESULTED IN A SIGNIFICANT REDUCTION OF PIS (P < 0.01) AND PFS (P < 0.01) AFTER 12 MONTHS. DURING THE STUDY, HOWEVER, YT WAS NOT SIGNIFICANTLY SUPERIOR COMPARED WITH SMC. SUBANALYSES FOR TIME POINTS DEMONSTRATED A SIGNIFICANT GREATER REDUCTION OF PIS AT 12 MONTHS IN FAVOR OF YT. NO DIFFERENCES WERE FOUND FOR QOL. YT WAS MORE EFFECTIVE IN THE REDUCTION OF REPORTED MONTHLY SCHOOL ABSENCE (P = 0.03). CONCLUSION: AT 1-YEAR FOLLOW-UP, YT IN ADDITION TO STANDARD CARE WAS SUPERIOR COMPARED WITH SMC ACCORDING TO TREATMENT SUCCESS, PIS, AND REDUCTION OF SCHOOL ABSENCE. YT, HOWEVER, WAS NOT SIGNIFICANTLY MORE EFFECTIVE IN IMPROVING PFS OR QOL, COMPARED WITH SMC. 2016 16 1446 41 INDIVIDUALIZED YOGA FOR REDUCING DEPRESSION AND ANXIETY, AND IMPROVING WELL-BEING: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: DEPRESSION AND ANXIETY ARE LEADING CAUSES OF DISABILITY WORLDWIDE. CURRENT TREATMENTS ARE PRIMARILY PHARMACEUTICAL AND PSYCHOLOGICAL. QUESTIONS REMAIN ABOUT EFFECTIVENESS AND SUITABILITY FOR DIFFERENT PEOPLE. PREVIOUS RESEARCH SUGGESTS POTENTIAL BENEFITS OF YOGA FOR REDUCING DEPRESSION AND ANXIETY. THE AIM OF THIS STUDY IS TO INVESTIGATE THE EFFECTS OF AN INDIVIDUALIZED YOGA INTERVENTION. METHODS: A SAMPLE OF 101 PEOPLE WITH SYMPTOMS OF DEPRESSION AND/OR ANXIETY PARTICIPATED IN A RANDOMIZED CONTROLLED TRIAL COMPARING A 6-WEEK YOGA INTERVENTION WITH WAITLIST CONTROL. YOGA WAS ADDITIONAL TO USUAL TREATMENT. THE CONTROL GROUP WAS OFFERED THE YOGA FOLLOWING THE WAITLIST PERIOD. MEASURES INCLUDED DEPRESSION ANXIETY STRESS SCALE (DASS-21), KESSLER PSYCHOLOGICAL DISTRESS SCALE (K10), SHORT-FORM HEALTH SURVEY (SF12), SCALE OF POSITIVE AND NEGATIVE EXPERIENCE (SPANE), FLOURISHING SCALE (FS), AND CONNOR-DAVIDSON RESILIENCE SCALE (CD-RISC2). RESULTS: THERE WERE STATISTICALLY SIGNIFICANT DIFFERENCES BETWEEN YOGA AND CONTROL GROUPS ON REDUCTION OF DEPRESSION SCORES (-4.30; 95% CI: -7.70, -0.01; P = .01; ES -.44). DIFFERENCES IN REDUCED ANXIETY SCORES WERE NOT STATISTICALLY SIGNIFICANT (-1.91; 95% CI: -4.58, 0.76; P = .16). STATISTICALLY SIGNIFICANT DIFFERENCES IN FAVOR OF YOGA WERE ALSO FOUND ON TOTAL DASS (P = .03), K10, SF12 MENTAL HEALTH, SPANE, FS, AND RESILIENCE SCORES (P < .01 FOR EACH). DIFFERENCES IN STRESS AND SF12 PHYSICAL HEALTH SCORES WERE NOT STATISTICALLY SIGNIFICANT. BENEFITS WERE MAINTAINED AT 6-WEEK FOLLOW-UP. CONCLUSION: YOGA PLUS REGULAR CARE WAS EFFECTIVE IN REDUCING SYMPTOMS OF DEPRESSION COMPARED WITH REGULAR CARE ALONE. FURTHER INVESTIGATION IS WARRANTED REGARDING POTENTIAL BENEFITS IN ANXIETY. INDIVIDUALIZED YOGA MAY BE PARTICULARLY BENEFICIAL IN MENTAL HEALTH CARE IN THE BROADER COMMUNITY. 2016 17 2464 39 YOGA AS A THERAPEUTIC INTERVENTION IN THE MANAGEMENT OF DYSFUNCTIONAL UTERINE BLEEDING: A CONTROLLED PILOT STUDY. BACKGROUND: DYSFUNCTIONAL UTERINE BLEEDING (DUB) IS ONE OF THE MOST COMMON GYNECOLOGICAL DISORDERS ENCOUNTERED IN WOMEN DURING THE REPRODUCTIVE AGE. YOGA THERAPY HAS SHOWN PROMISING BENEFITS IN SEVERAL GYNECOLOGICAL DISORDERS. METHODS: THIRTY WOMEN BETWEEN THE AGES OF 20 AND 40 YEARS WITH PRIMARY DUB WERE RANDOMLY ASSIGNED TO A YOGA (N = 15) AND A WAITLIST CONTROL GROUP (N = 15). PARTICIPANTS IN THE YOGA GROUP RECEIVED A 3-MONTH YOGA MODULE AND WERE ASSESSED FOR HEMOGLOBIN VALUES, ENDOMETRIAL THICKNESS (ET), PICTORIAL BLOOD LOSS ASSESSMENT CHART (PBAC), STATE-TRAIT ANXIETY INVENTORY, PERCEIVED STRESS SCALE, AND PITTSBURGH SLEEP QUALITY INDEX (PSQI) BEFORE AND AFTER A 3-MONTH FOLLOW-UP PERIOD. RESULTS: AT THE END OF 3 MONTHS OF INTERVENTION, THE YOGA GROUP, UNLIKE THE CONTROL GROUP, REPORTED A SIGNIFICANT REDUCTION IN THE ANXIETY SCORES (P < 0.05) AND PERCEIVED STRESS (P < 0.05). THE PSQI SCORES INDICATED A REDUCTION IN SLEEP DISTURBANCES (P < 0.001) AND THE NEED FOR SLEEP MEDICATIONS (P < 0.01) AND HIGHER GLOBAL SCORES (P < 0.001). HOWEVER, THERE WERE NO CHANGES IN PBAC AND ET IN BOTH THE GROUPS. CONCLUSION: THE RESULTS INDICATE THAT YOGA THERAPY POSITIVELY IMPACTS THE OUTCOME OF DUB BY REDUCING THE PERCEIVED STRESS AND STATE ANXIETY AND IMPROVING THE QUALITY OF SLEEP. THIS WARRANTS LARGER CLINICAL TRIALS TO VALIDATE THE FINDINGS OF THIS PILOT STUDY. 2018 18 657 26 EFFECT OF 'EXERCISE WITHOUT MOVEMENT' YOGA METHOD ON MINDFULNESS, ANXIETY AND DEPRESSION. OBJECTIVE: TO ANALYZE THE EFFECT OF THE 'EXERCISE WITHOUT MOVEMENT' (E.W.M) YOGA METHOD ON MINDFULNESS AND ON THE IMPROVEMENT OF ANXIETY AND DEPRESSION SYMPTOMS. METHODS: A QUASI-EXPERIMENTAL STUDY EXAMINED THE EFFECT OF ONE MONTH E.W.M. INTERVENTION AMONG 38 PARTICIPANTS WHO WERE ENROLLED VOLUNTARILY TO BOTH GROUPS, STUDY (N = 16) AND CONTROL (N = 22). FIVE PARTICIPANTS DROPPED OUT DURING THE STUDY. THE STATE MINDFULNESS SCALE (SMS) WAS USED TO MEASURE MINDFULNESS. THE ANXIETY INVENTORY BECK (BAI) AND THE BECK DEPRESSION INVENTORY (BDI-II) WERE USED TO MEASURE THE ANXIETY AND DEPRESSION SYMPTOMS, RESPECTIVELY, BEFORE AND AFTER THE INTERVENTION. RESULTS: STUDY GROUP SHOWED BOTH A STATISTICALLY SIGNIFICANT INCREASE IN MINDFULNESS AND DECREASE IN ANXIETY AND DEPRESSION SYMPTOMS, COMPARED WITH THE CONTROL GROUP. CONCLUSIONS: THE E.W.M. HAS BEEN USEFUL IN THE DEVELOPMENT OF MINDFULNESS AND IN THE TREATMENT OF ANXIETY AND DEPRESSION SYMPTOMS AND MAY REPRESENT A NEW METHOD IN THE MINDFULNESS-BASED THERAPEUTIC APPLICATION. 2016 19 1571 30 MANAGEMENT OF MYOFASCIAL PAIN DYSFUNCTION SYNDROME WITH MEDITATION AND YOGA: HEALING THROUGH NATURAL THERAPY. AIMS AND OBJECTIVES: AIMS AND OBJECTIVES OF THE STUDY WERE TO STUDY THE EFFECTIVENESS OF RAJ-YOGA MEDITATION AND PRANAYAMA IN PATIENTS WITH MYOFASCIAL PAIN DYSFUNCTION SYNDROME (MPDS) AND COMPARED THE EFFECTS WITH ONGOING CONVENTIONAL NONINVASIVE TREATMENT MODALITIES. MATERIALS AND METHODS: THE STUDY COMPRISED 30 PATIENTS DIVIDED EQUALLY (10 EACH) INTO 3 GROUP, I.E., CONTROL GROUP (CONVENTIONAL, NONINVASIVE TREATMENT), EXPERIMENTAL A GROUP (CONVENTIONAL, NONINVASIVE TREATMENT WITH RAJ-YOGA MEDITATION THERAPY AND PRANAYAMA), AND EXPERIMENTAL B GROUP (RAJ-YOGA MEDITATION THERAPY AND PRANAYAMA ONLY). PARAMETERS SUCH AS PAIN, MOUTH OPENING, MANDIBULAR DEVIATION, INFLAMMATION, SWELLING, CLICKING, OCCLUSION, AND PSYCHOLOGIC EVALUATION SUCH AS ANXIETY, STRESS, AND DEPRESSION WERE ASSESSED BEFORE THE START OF THE STUDY AND AT WEEKLY INTERVALS FOR 3 MONTHS. RESULTS: POSTTREATMENT PAIN AND INFLAMMATION IMPROVED BOTH IN THE CONTROL GROUP AND EXPERIMENTAL A GROUP, BUT STATISTICALLY IT IS HIGHLY SIGNIFICANT IN THE EXPERIMENTAL A GROUP. FURTHERMORE, IT IS EFFECTIVE IMMEDIATELY AS WELL AS FOR A LONG PERIOD IN EXPERIMENTAL A GROUP. IMPROVEMENT IN MOUTH OPENING WAS STATISTICALLY HIGHLY SIGNIFICANT IN CONTROL GROUP BUT NOT IN THE EXPERIMENTAL GROUPS. POSTTREATMENT ANXIETY AND STRESS STATUS WAS IMPROVED WITH STATISTICALLY HIGHLY SIGNIFICANT RESULT IN THE EXPERIMENTAL A AND B. THE POSTTREATMENT DEPRESSION STATUS ALONG WITH MANDIBULAR DEVIATION, SWELLING, CLICKING, AND OCCLUSION HAS NOT IMPROVED SIGNIFICANTLY IN ANY OF THE GROUPS. INTERPRETATION AND CONCLUSION: RAJ-YOGA MEDITATION AND PRANAYAMA IN COMBINATION WITH CONVENTIONAL, NONINVASIVE, TREATMENT MODALITIES SHOWED PROMISING RESULTS IN MPDS PATIENTS AS COMPARED TO EITHER MODALITIES ALONE. 2018 20 819 35 EFFECT OF YOGA ON DEPRESSION IN HYPOTHYROIDISM: A PILOT STUDY. BACKGROUND: THE PREVALENCE OF HYPOTHYROIDISM AMONG INDIAN WOMEN IS 15.8%. DEPRESSION IS FREQUENTLY REPORTED IN HYPOTHYROIDISM. YOGA IS AN EFFECTIVE INTERVENTION FOR DEPRESSION. HOWEVER, THE INFLUENCE OF YOGA ON DEPRESSION IN PATIENTS WITH HYPOTHYROIDISM HAS NOT BEEN STUDIED. AIM: THE PRESENT STUDY INVESTIGATED THE EFFECT OF A 3-MONTH INTEGRATED YOGA INTERVENTION (3-IY) ON DEPRESSION, LIPID INDICES, AND SERUM THYROID-STIMULATING HORMONE (STSH) LEVELS AMONG FEMALE PATIENTS HAVING HYPOTHYROIDISM, AND MILD-TO-MODERATE DEPRESSION. METHOD: THE PRESENT SINGLE-ARM PRE-POST DESIGN STUDY WAS CONDUCTED IN THIRTY-EIGHT WOMEN (AVERAGE AGE 34.2 +/- 4.7 YEARS). PARTICIPANTS RECEIVED A 3-IY COMPRISING ASANAS, PRANAYAMA, AND RELAXATION TECHNIQUES FOR 60 MIN DAILY (5 DAYS A WEEK). DEPRESSION, STSH, LIPID PROFILE INDICES, BODY MASS INDEX (BMI), FATIGUE, ANXIETY, AND STRESS WERE ASSESSED AT BASELINE AND AFTER 12 WEEKS. THYROID MEDICATION WAS KEPT CONSTANT DURING THE STUDY PERIOD. DATA WERE ANALYSED USING R STUDIO SOFTWARE. RESULT: A SIGNIFICANT (P < 0.05) REDUCTION IN DEPRESSION (58%), STSH (37%), BMI (6%), FATIGUE (64%), ANXIETY (57%), LIPID PROFILE INDICES (HLD INCREASED SIGNIFICANTY), AND STRESS (55%) LEVELS WAS OBSERVED AFTER 3 MONTHS, COMPARED WITH THE CORRESPONDING BASELINE LEVELS. CONCLUSION: THE 3-IY IS USEFUL FOR REDUCING DEPRESSION, DYSLIPIDEMIA, AND STSH IN WOMEN WITH HYPOTHYROIDISM AND DEPRESSION. FURTHER STUDIES WITH A LARGER SAMPLE SIZE AND A ROBUST RESEARCH DESIGN USING OBJECTIVE VARIABLES MUST BE CONDUCTED TO STRENGTHEN THE STUDY FINDINGS. 2021